Neurocrine Biosciences, Inc. (0K6R.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
95.27+0.14 (+0.15%)
As of 3:50PM BST. Market open.
| Previous close | 95.13 |
| Open | 95.27 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 95.27 - 95.27 |
| 52-week range | 95.27 - 95.27 |
| Volume | 0 |
| Avg. volume | N/A |
| Market cap | 9.376B |
| Beta (5Y monthly) | 0.77 |
| PE ratio (TTM) | 23.28 |
| EPS (TTM) | 4.09 |
| Earnings date | 08 Nov 2021 - 12 Nov 2021 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Those who invested in Neurocrine Biosciences (NASDAQ:NBIX) five years ago are up 79%
If you buy and hold a stock for many years, you'd hope to be making a profit. Furthermore, you'd generally like to see...
- Simply Wall St.
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?
It is hard to get excited after looking at Neurocrine Biosciences' (NASDAQ:NBIX) recent performance, when its stock has...
- Motley Fool
Neurocrine Biosciences, inc (NBIX) Q2 2021 Earnings Call Transcript
NBIX earnings call for the period ending June 30, 2021.
© 2021 Verizon Media. All rights reserved.
